Articles

The U.S. was supposed to be in recession by now because of rising interest rates. Instead a resilient economy is seeking to pull off a third "two-fer" in a row.

Prices for gasoline, diesel and jet fuel jump this summer. Here's what may lie ahead.

Biotech's stock is up 13% in the week to date after Novo Nordisk said its Wegovy obesity treatment reduced the risk of cardio events by 20% in obese adults.

Rocket Lab reported better-than-expected second-quarter results this week.

A screen of stocks in industries related to EVs and autonomous driving highlights companies expected to grow most quickly from elevated 2023 baselines.

The financial market's savviest inflation traders are bracing for Thursday's release of the consumer price index for July to reaffirm that U.S. inflation remains on a rocky road toward 2% in the months to come.

A team of 17 Morgan Stanley analysts have broken down the impact that drugs like Wegovy and Ozempic may have on food companies.

The number of people making 'hardship' or emergency withdrawals from their 401(k) plans is soaring.

Praise for Rivian Automotive Inc.'s better-than-expected quarterly results failed to boost the EV maker's stock on Wednesday, with most analysts keeping their cautious view on the company and on the direction of the stock in the near term.

A screen of 144 stocks in industries related to electric vehicles and autonomous driving shows analysts expect the high-tech build-out to continue.

China's biggest property developer, Country Garden, defaulted on interest payments on dollar-denominated debt with a face value of $1 billion.

Fixed income was hit by rising interest rates, but it’s a small share of plan portfolios